ArticleIrish journal of medical science2026
Differentiating pulmonary sarcoidosis from pulmonary tuberculosis in clinical practice: Insights from routine blood tests.
Article in Irish journal of medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPulmonary sarcoidosis and pulmonary tuberculosis are both diseases that affect hundreds of thousands of people worldwide. Because both present with granulomatous inflammation in clinical practice, distinguishing tuberculosis from sarcoidosis can be difficult. This study hypothesised that parameters, such as monocyte, and albumin levels, and red blood cell distribution width and mean platelet volume ratio, can help differentiate sarcoidosis from tuberculosis. MATERIALS AND
methodsWe included 203 patients with sarcoidosis and 200 with tuberculosis in the study after excluding those with misdiagnoses or insufficient data. The neutrophil-lymphocyte ratio and platelet-lymphocyte ratio were obtained by dividing neutrophil and platelet levels by lymphocyte count. The blood parameters belong to the period of the first diagnosis before starting a treatment.
resultsThe sarcoidosis group had higher levels of mean platelet volume, platelet distribution width, and albumin, whereas they had lower levels of red blood cell distribution width, red blood cell distribution width/platelet distribution width, and red blood cell distribution width/mean platelet volume. Levels above 42.95 g/L for albumin and below 3.72 g/L for red blood cell distribution width/platelet distribution width promote sarcoidosis.
conclusionLower monocyte levels, red blood cell distribution width, red blood cell distribution width/platelet distribution width, and red blood cell distribution width/mean platelet volume, along with higher levels of mean platelet volume, platelet distribution width, platelets, albumin, and lymphocyte-monocyte ratio, may favour sarcoidosis over tuberculosis.
Indexed as
Identifiers
42667592What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.